Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL246076 | 0.75 | — | — | |
| SCHEMBL8575584 | 0.72 | MEN1 (0.33) | MEN1KMT2ATDP1 | |
| SCHEMBL733456 | 0.72 | MEN1 (0.33) | MEN1KMT2ATDP1 | |
| SCHEMBL8568331 | 0.72 | MEN1 (0.33) | MEN1KMT2ATDP1 | |
| SCHEMBL104139 | 0.72 | MEN1 (0.33) | MEN1KMT2ATDP1 | |
| SCHEMBL720011 | 0.72 | MEN1 (0.33) | MEN1KMT2ATDP1 | |
| SCHEMBL8565493 | 0.72 | MEN1 (0.33) | MEN1KMT2ATDP1 | |
| SCHEMBL8573056 | 0.72 | MEN1 (0.33) | MEN1KMT2ATDP1 | |
| SCHEMBL8569527 | 0.72 | MEN1 (0.33) | MEN1KMT2ATDP1 | |
| SCHEMBL8566528 | 0.72 | MEN1 (0.33) | MEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10563107-B2 | Compositions comprising fluoroolefins and uses thereof | THE CHEMOURS COMPANY FC, LLC (US) | 2020-02-18 | — | — | US | disclosed |
| US-20180127628-A1 | COMPOSITIONS COMPRISING FLUOROOLEFINS AND USES THEREOF | JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT | 2018-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10563107-B2 | Compositions comprising fluoroolefins and uses thereof | GFPT1, PFAS, TRMT1 | MEN1 1458/4885KMT2A 4409/4885TDP1 1435/4885 |
| US-20180127628-A1 | COMPOSITIONS COMPRISING FLUOROOLEFINS AND USES THEREOF | GFPT1, PFAS, TRMT1 | MEN1 1458/4885KMT2A 4409/4885TDP1 1435/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.